JP2022521792A5 - - Google Patents
Info
- Publication number
- JP2022521792A5 JP2022521792A5 JP2021550014A JP2021550014A JP2022521792A5 JP 2022521792 A5 JP2022521792 A5 JP 2022521792A5 JP 2021550014 A JP2021550014 A JP 2021550014A JP 2021550014 A JP2021550014 A JP 2021550014A JP 2022521792 A5 JP2022521792 A5 JP 2022521792A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- dna
- cell
- cancer vaccine
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811459P | 2019-02-27 | 2019-02-27 | |
| US62/811,459 | 2019-02-27 | ||
| US201962825487P | 2019-03-28 | 2019-03-28 | |
| US62/825,487 | 2019-03-28 | ||
| US201962838180P | 2019-04-24 | 2019-04-24 | |
| US62/838,180 | 2019-04-24 | ||
| US201962881832P | 2019-08-01 | 2019-08-01 | |
| US62/881,832 | 2019-08-01 | ||
| PCT/US2020/020224 WO2020176797A1 (en) | 2019-02-27 | 2020-02-27 | Immunotherapeutic combination for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521792A JP2022521792A (ja) | 2022-04-12 |
| JP2022521792A5 true JP2022521792A5 (cg-RX-API-DMAC7.html) | 2023-03-06 |
Family
ID=72238533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021550014A Pending JP2022521792A (ja) | 2019-02-27 | 2020-02-27 | 癌を治療するための免疫療法的併用 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3930747A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022521792A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113631185A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020176797A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230165952A1 (en) | 2020-05-01 | 2023-06-01 | Nykode Therapeutics ASA | Betacoronavirus prophylaxis and therapy |
| AU2022244191A1 (en) * | 2021-03-26 | 2023-09-28 | Nykode Therapeutics ASA | Therapeutic combination for treating cancer |
| KR20240004403A (ko) * | 2021-03-29 | 2024-01-11 | 오디 쎄라퓨틱스 리미티드 | 단백질-거대분자 접합체 및 이의 사용 방법 |
| WO2022233851A1 (en) | 2021-05-03 | 2022-11-10 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseases |
| WO2022238363A1 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseases |
| WO2022238381A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunotherapy constructs for treatment of disease |
| EP4337247A1 (en) | 2021-05-10 | 2024-03-20 | Nykode Therapeutics ASA | Tolerance-inducing constructs and compositions and their use for the treatment of immune disorders |
| IL308310A (en) | 2021-05-10 | 2024-01-01 | Nykode Therapeutics ASA | Co-expression of immune-stimulating structures and compounds |
| WO2022238432A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Co-expression of constructs and immunoinhibitory compounds |
| KR20240007235A (ko) | 2021-05-10 | 2024-01-16 | 니코데 테라퓨틱스 에이에스에이 | 관용-유도 컨스트럭트 및 조성물 및 면역 장애의 치료를 위한 그들의 용도 |
| EP4426344A1 (en) | 2021-11-03 | 2024-09-11 | Nykode Therapeutics ASA | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of diseases caused by sars-cov-2 |
| WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
| US20260193669A1 (en) | 2022-11-09 | 2026-07-09 | Nykode Therapeutics ASA | Co-Expression of Constructs and Polypeptides |
| CN116217676B (zh) * | 2023-01-30 | 2025-07-29 | 广州呈源生物免疫技术有限公司 | 人乳头瘤病毒抗原肽及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016025647A1 (en) * | 2014-08-12 | 2016-02-18 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2, a therapeutic antibody, and a cancer vaccine |
| TW201708536A (zh) * | 2015-05-26 | 2017-03-01 | 艾法西斯公司 | 個人化的基於遞送載體之免疫療法及其用途 |
| JP2019505512A (ja) * | 2016-01-08 | 2019-02-28 | バッシボディ アクスイェ セルスカプ | 治療用抗癌ネオエピトープワクチン |
| SG11201808196UA (en) * | 2016-03-31 | 2018-10-30 | Neon Therapeutics Inc | Neoantigens and methods of their use |
| AU2017315468B2 (en) * | 2016-08-25 | 2020-02-13 | Nantomics, Llc | Immunotherapy markers and uses therefor |
| CA3043597A1 (en) * | 2016-11-10 | 2018-05-17 | Nektar Therapeutics | Immunotherapeutic tumor treatment method |
| KR20240113607A (ko) * | 2017-06-21 | 2024-07-22 | 트랜스진 | 개인 맞춤형 백신 |
-
2020
- 2020-02-27 CN CN202080025990.8A patent/CN113631185A/zh active Pending
- 2020-02-27 EP EP20763489.0A patent/EP3930747A4/en not_active Withdrawn
- 2020-02-27 WO PCT/US2020/020224 patent/WO2020176797A1/en not_active Ceased
- 2020-02-27 JP JP2021550014A patent/JP2022521792A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marin-Acevedo et al. | Cancer immunotherapy beyond immune checkpoint inhibitors | |
| Pollack et al. | Emerging targeted and immune-based therapies in sarcoma | |
| Kiesgen et al. | Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies | |
| KR102470294B1 (ko) | 암을 치료하기 위한 항-pd1 항체 및 방사선의 조합 | |
| Dammeijer et al. | Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors | |
| Coukos et al. | Opportunities in immunotherapy of ovarian cancer | |
| Goel et al. | Cancer immunotherapy in clinical practice—the past, present, and future | |
| MX2021011500A (es) | Anticuerpos multiespecificos egfr x cd28. | |
| FI3886875T3 (fi) | Adoptiivista soluterapiaa käyttäviä hoitomenetelmiä | |
| JP2017531687A5 (cg-RX-API-DMAC7.html) | ||
| Martin et al. | Emerging Therapeutic Options for HER2-Positive Breast Cancer. | |
| RU2014111999A (ru) | Антитела к C10RF32 и их применения для лечения рака | |
| Houot et al. | Vaccines for lymphomas: idiotype vaccines and beyond | |
| JP2017523784A5 (cg-RX-API-DMAC7.html) | ||
| JP2022532490A5 (cg-RX-API-DMAC7.html) | ||
| RU2016147206A (ru) | Полипептиды и полинуклеотиды и их применение для лечения иммунологических нарушений и рака | |
| Berinstein | Enhancing cancer vaccines with immunomodulators | |
| RU2013155455A (ru) | Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6 | |
| RU2011115117A (ru) | Нацеленные средства связывания, направленные на dll4, и их применение | |
| JP2014502955A5 (cg-RX-API-DMAC7.html) | ||
| CN113543809A (zh) | 用于治疗癌症的免疫疗法 | |
| IL300629A (en) | Preparations and methods for the treatment of EGFR positive cancer | |
| JP2022512944A5 (cg-RX-API-DMAC7.html) | ||
| Ströhlein et al. | The current status of immunotherapy in peritoneal carcinomatosis | |
| JP2022512384A5 (cg-RX-API-DMAC7.html) |